Inside the Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology
47,95 €
Yet there are thousands of much less common diseases, most of genetic origin, each classed as "rare" because it afflicts only a small number of people. The passage of the 1983 U.S. Orphan Drug Act resulted from public pressure brought by rare disease patients, their families, and advocates.
Jetzt bei Ebay:
![Produktbild - The Bristol Orphan Houses, Ashley Down by William Elfe Tayler [Paperback]](https://i.ebayimg.com/thumbs/images/g/HNYAAOSwgDJm2j35/s-l140.jpg)
![Produktbild - Ethics and Biotechnology by Dyson, Anthony [Paperback]](https://i.ebayimg.com/thumbs/images/g/mpwAAOSwYXtmqr0E/s-l140.jpg)
